Browse EX-10 agreements

AMICUS THERAPEUTICS, INC.

2025 EQUITY INCENTIVE PLAN

RESTRICTED STOCK UNIT AWARD AGREEMENT

BioMarin Pharmaceutical Inc. (the “Company”) pursuant to the Amicus Therapeutics, Inc. 2025 Equity Incentive Plan, as assumed, amended and restated effective April 27, 2026, and as it may be further amended from time to time (the “Plan”) hereby grants you a number of restricted stock units (“RSUs”) in the amount set forth below (the “Award”). The Award is subject to all of the terms and conditions set forth in this Restricted Stock Unit Award Agreement, including the exhibits, appendices and addenda attached hereto (this “Agreement”) and the Plan. Unless otherwise defined herein, the terms defined in the Plan shall have the same defined meanings in this Agreement.

I.NOTICE OF AWARD OF RSUs

A.Terms of the Award. You have been granted RSUs, each of which represents the right to receive one share of Common Stock of the Company (a “Share” and collectively, the “Shares”), subject to the terms and conditions of the Plan and this Agreement, as follows:

…

BioMarin Pharmaceutical Inc.
2017 Equity Incentive Plan

Adopted by the Compensation Committee of the Board of Directors: April 10, 2017

Approved by the Stockholders: June 6, 2017

Amended by the Compensation Committee of the Board of Directors: April 12, 2019

Amendment Approved by the Stockholders: June 4, 2019

Amended by the Compensation Committee of the Board of Directors: April 5, 2021

Amendment Approved by the Stockholders: May 25, 2021

Amended by the Compensation Committee of the Board of Directors: April 3, 2023

Amendment Approved by the Stockholders: May 23, 2023

Amended by the Compensation Committee of the Board of Directors: April 1, 2025

Amendment Approved by the Stockholders: May 20, 2025

Amended by the Compensation Committee of the Board of Directors: April 14, 2026

Amendment Approved by the Stockholders: June 2, 2026

1.General.

…

AMICUS THERAPEUTICS, INC. 2025 EQUITY INCENTIVE PLAN

(As Assumed, Amended and Restated, Effective April 27, 2026)

On April 27, 2026, BioMarin Pharmaceutical Inc. (“BioMarin”) completed a merger (the “Merger”) whereby Lynx Merger Sub 1, Inc., a Delaware corporation and wholly owned subsidiary of BioMarin merged with and into Amicus Therapeutics, Inc., a Delaware corporation (“Amicus”), with Amicus surviving the Merger (the consummation of such Merger, the “Closing”). Pursuant to the Merger, Amicus became a wholly owned subsidiary of BioMarin. In connection with the Merger, the Amicus Therapeutics, Inc. 2025 Equity Incentive Plan (the “Plan”) was assumed by BioMarin.

Accordingly, effective as of the Closing the Plan is hereby assumed, amended and restated as set forth herein, in order to reflect the actions described in the preceding paragraph.

1.Purpose

…

AMICUS THERAPEUTICS, INC.

2025 EQUITY INCENTIVE PLAN

STOCK OPTION AWARD AGREEMENT

BioMarin Pharmaceutical Inc. (the “Company”) pursuant to the Amicus Therapeutics, Inc. 2025 Equity Incentive Plan, as assumed, amended and restated, effective April 27, 2026, and as it may be further amended from time to time (the “Plan”) hereby grants you an option to purchase the number of shares of Common Stock in the amount set forth below (the “Option”). The Option is subject to all of the terms and conditions set forth in this Stock Option Award Agreement, including the exhibits, appendices and addenda attached hereto (this “Agreement”) and the Plan. Unless otherwise defined herein, the terms defined in the Plan shall have the same defined meanings in this Agreement.

I.NOTICE OF STOCK OPTION GRANT

A.Terms of the Option. You have been granted an Option to purchase shares of Common Stock of the Company (the “Option Shares”), subject to the terms and conditions of the Plan and this Agreement, as follows:

…

RESTRICTED STOCK UNIT GRANT NOTICE UNDER THE US FOODS HOLDING CORP. 2019 LONG-TERM INCENTIVE PLAN

(Time-Based Restricted Stock Unit Award)

US Foods Holding Corp. (the “Company”), pursuant to the US Foods Holding Corp. 2019 Long-Term Incentive Plan (the “Plan”), hereby grants to the Participant set forth below the number of Restricted Stock Units set forth below.The Restricted Stock Units are subject to all the terms and conditions as set forth herein, in the Restricted Stock Unit Agreement attached hereto, and in the Plan, all of which are incorporated herein in their entirety. Capitalized terms not otherwise defined herein shall have the meaning set forth in the Plan.

…

ArtivaBiotherapeutics,Inc.|5505 Morehouse Drive, Suite 100,SanDiegoCA

//

ArtivaBiotherapeutics,Inc.|5505 Morehouse Drive, Suite 100,SanDiegoCA

//

Exhibit 10.2

May 18, 2026

Diego Miralles

Via email: [***] Private & Confidential

Dear Diego,

On behalf of Artiva Biotherapeutics, Inc. (the “Company”), I am pleased to offer you employment under the terms set forth in this offer letter agreement (this “Agreement”). These employment terms will be effective as of your start date, which will be on May 18, 2026 (the “Start Date”). This offer is contingent upon approval by the Company’s Board of Directors (the “Board”), upon your resignation from the Board, and upon your successful completion of a background check to the satisfaction of the Company.

1.

…

May 18, 2026

Thad Huston

[***]

Re: Separation Agreement

Dear Thad:

This letter confirms your separation from Artiva Biotherapeutics, Inc.(the “Company”) effective May 22, 2026, and sets forth the terms of your separation.

1.

SEPARATION.If you timely sign this Agreement, your employment with the Company will continue through May 22, 2026, unless terminated earlier. The actual date your employment ends shall be your “Separation Date.” If you choose not to accept this Agreement, or you revoke it after you sign it, then you will not be entitled to any further compensation or benefits (including, without limitation, the severance benefits set forth in Section 4) from that date.

2.

ACCRUED WAGES PAID TIME OFF.On the Separation Date, the Company will pay you all accrued wages, and all accrued and unused paid time off earned through the Separation Date, subject to standard payroll deductions and withholdings. You are entitled to these payments regardless of whether or not you sign this Agreement.

3.

…

VERASTEM, INC.

AMENDED AND RESTATED 2021 EQUITY INCENTIVE PLAN

1.DEFINED TERMS

Exhibit A, which is incorporated by reference, defines certain terms used in the Plan and includes certain operational rules related to those terms.  

2.PURPOSE

The Plan has been established to advance the interests of the Company by providing for the grant to Participants of Stock and Stock-based Awards.

3.ADMINISTRATION

The Plan will be administered by the Administrator.  The Administrator has discretionary authority, subject only to the express provisions of the Plan, to administer and interpret the Plan and any Awards; to determine eligibility for and grant Awards; to determine the exercise price, base value from which appreciation is measured, or purchase price, if any, applicable to any Award, to determine, modify, accelerate or waive the terms and conditions of any Award; to determine the form of settlement of Awards (whether in cash, shares of Stock, other Awards, other property or a combination thereof); to prescribe forms, rules and procedures relating to the Plan

…

VERASTEM, INC.

AMENDED AND RESTATED

2018 EMPLOYEE STOCK PURCHASE PLAN

​

1)Defined Terms

Exhibit A, which is incorporated by reference, defines certain terms used in the Plan and sets forth certain operational rules related to those terms.

2)Purpose of Plan

The Plan is intended to enable Eligible Employees to use payroll deductions to purchase shares of Stock in offerings under the Plan and thereby acquire an interest in the future of the Company.  The Plan is intended to qualify as an “employee stock purchase plan” under Section 423 and to be exempt from the application and requirements of Section 409A of the Code and is to be construed accordingly.

3)Options to Purchase Stock

…

AMENDMENT TO
TRANSITION AND SEPARATION AGREEMENT

This Amendment to the Transition and Separation Agreement (the “Amendment”) is made by and between Michael Szabados (“Employee” or “you”) and NetScout Systems, Inc. (the “Company”) (collectively referred to as the “Parties” or individually referred to as a “Party”).

RECITALS

WHEREAS, the Parties previously entered into a Transition and Separation Agreement (the “Original Agreement”) pursuant to which Employee transitioned to a position of “Senior Advisor” until June 30, 2026, unless earlier terminated pursuant to the terms contained herein;

WHEREAS, the Parties now wish to provide for Employee’s continuation as a non-employee advisor following the end of the Senior Advisor Period; and

WHEREAS, the Parties have read and understand the terms of this Amendment, and both Parties have been provided with reasonable opportunities to consult with their respective legal counsel prior to entering this Agreement.

THEREFORE, the Parties agree to amend the Original Agreement as follows:

1.

Post-Senior Advisor Period

(a)

…

NETSCOUTSYSTEMS,INC.

2019 EQUITY INCENTIVE PLAN

PERFORMANCE-BASED RESTRICTED STOCK UNIT AWARD NOTICE AND AGREEMENT

NetScoutSystems, Inc.(the “Company”) hereby enters intothis Performance-Based Restricted Stock Unit AwardAgreement,including theTermsandConditions,andany appendix,exhibitoraddendumattached hereto(the “Agreement”),as of the date of grant specified below, with the recipient specified below (the “Recipient”),and grantsto the Recipient the numberofperformance-based restricted stock units(the“PSUs”)specified below pursuant to theCompany’s2019 EquityIncentive Plan,as amendedand in effect fromtime to time.Unless otherwise defined hereinor required by the context,capitalized terms used hereinshallhave thesame meaningsas inthe PlanortheAgreement.

…

Doximity Board Compensation Policy

Effective July 22, 2026

Equity Compensation for Non-Employee Directors:

Initial RSU grants:Number of units valued at $400,000 based on the closing price on the date of grant, to vest in equal parts annually over three years (one-third at each anniversary). Grants shall be issued automatically on the date of the new director’s term of service (unless the Compensation Committee determines otherwise).

Annual RSU grants:Number of units valued at $200,000 based on the closing price on the date of grant, to vest on the earlier of the one-year anniversary of the grant or the next Annual Shareholder Meeting. Grants shall be issued automatically on the date of each Annual Shareholder Meeting (unless the Compensation Committee determines otherwise, or unless the recipient director received an initial grant within the immediately preceding three months, in which case that director will receive the next available annual grant).

Stock ownership requirements:Not required by the Committee at this time.

Cash Compensation for Non-Employee Directors:

…